Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04709562 · ClinicalTrials.gov registry record · NA
Clinical Stabilization of Hypercapnia: NIPPV v HVNI
A NA study, sponsored by Vapotherm.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT04709562 is a NA study that has completed, run by Vapotherm. The registered enrollment target is 68 participants.
The verdict
NCT04709562, a NA study, has completed, sponsored by Vapotherm.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
This study will evaluate the ability of High Velocity Nasal Insufflation \[HVNI\] to effect ventilation and related physiologic responses in hypercapnic patients when compared to noninvasive positive pressure ventilation \[NIPPV\].
Interventions
- DEVICE High Velocity Nasal Insufflation (HVNI)
- DEVICE Noninvasive Positive Pressure Ventilation (NIPPV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-11-11 |
| Est. Completion | 2023-06-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04709562
The ClinicalTrials.gov registry entry for NCT04709562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vapotherm, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Velocity Nasal Insufflation (HVNI) is the first listed.
NCT04709562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04709562 about?
NCT04709562 is a clinical study titled "Clinical Stabilization of Hypercapnia: NIPPV v HVNI". This study will evaluate the ability of High Velocity Nasal Insufflation \[HVNI\] to effect ventilation and related physiologic responses in hypercapnic patients when compared to noninvasive positive pressure ventilation \[NIPPV\].
What is the current status of trial NCT04709562?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2020-11-11. Estimated completion is 2023-06-22.
What interventions are being tested in trial NCT04709562?
The interventions under investigation include: High Velocity Nasal Insufflation (HVNI) (DEVICE), Noninvasive Positive Pressure Ventilation (NIPPV) (DEVICE).
Who is sponsoring clinical trial NCT04709562?
This trial is sponsored by Vapotherm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.